Related Experiment Video
Updated: Jul 8, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Clinical management of EGFRI-associated dermatologic toxicities: pharmacy perspective
1The Moses Cone Regional Cancer Center, Greensboro, North Carolina 27403-1199, USA. Lew.Iacovelli@mosescone.com
Abstract:
This article describes agents used to treat the dermatologic toxicities commonly seen during therapy with epidermal growth factor receptor inhibitors. Therapeutic options include topical emollients, antibiotics, corticosteroids, and other agents for supportive care. While medical approaches to these adverse reactions are still in a "learning phase," continued experience will provide further insight into effective management strategies.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Treatment Strategies
Clinical Applications of Epidermal Stem Cells
Nephrotic Syndrome III : Nursing Management
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
